EUVIMEDEUVIMED entdecken
Systematische Übersicht

Liver Injury Associated With Kratom (Mitragyna speciosa): A Systematic Review

Xavier Alexander Calicdan iD, Anika Kopczynski, Edwin Medina, Samantha Singh, Diana Sotelo, Alexander Chen Wu, Joji Suzuki

Journal of Addiction Medicine · 2026-11 · 20 (6) · e230-e238

DOI: 10.1097/adm.0000000000001663 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Addiction Medicine, online erschienen am 10.03.2026. Verfasst von Xavier Alexander Calicdan und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mitragyna, Chemical and Drug Induced Liver Injury, Plant Extracts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Kratom ( Mitragyna speciosa ) is a psychoactive herbal product increasingly used for pain, anxiety, and opioid withdrawal. Although marketed as a natural dietary product, concerns have emerged regarding adverse effects like cardiotoxicity, seizures, opioid-like physical dependence, and, particularly, liver toxicity.

Methods

We conducted a systematic review following PRISMA 2020 guidelines of all studies on kratom use and liver toxicity.

Results

Thirty-one studies were included, comprising 32 cases of kratom-associated liver injury. Most reports originated from the United States and were single-patient case reports. Most patients were adult males, with frequent co-occurrence of polysubstance use and comorbid conditions. Concomitant exposures were commonly reported but variably characterized across studies. Baseline liver disease was present in 3 patients (9%). Kratom dose, form, frequency, and duration were inconsistently reported. Only 7 cases (22%) provided complete exposure details, whereas the remainder lacked one or more elements. Kratom use was temporally associated with the onset of liver injury, commonly presenting with jaundice and elevations in liver enzymes. The patterns of injury were predominantly cholestatic. In most cases, liver enzymes and function improved after cessation of kratom use. In 4 cases, the patient’s liver function did not improve and progressed to liver transplantation. Although formal causality assessments were inconsistently reported, many reports supported an association based on exclusion of alternative etiologies and, in some cases, rechallenge episodes.

Conclusions

Further research is needed to better characterize kratom’s mechanisms of liver injury and to inform clinical decision-making and public health policy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitragynaChemical and Drug Induced Liver InjuryPlant ExtractsHumansMale

Stichwörter der Autor:innen

kratomliver injurymitragynine

Substanzen

Plant Extracts

Autor:innen und Institutionen

ORCID-Profile: Xavier Alexander Calicdan

Zitieren

APA

Calicdan, X. A., Kopczynski, A., Medina, E., Singh, S., Sotelo, D., Wu, A. C., & Suzuki, J. (2026). Liver Injury Associated With Kratom (Mitragyna speciosa): A Systematic Review. Journal of Addiction Medicine, 20(6), e230-e238. https://doi.org/10.1097/adm.0000000000001663

Vancouver

Calicdan XA, Kopczynski A, Medina E, Singh S, Sotelo D, Wu AC, et al. Liver Injury Associated With Kratom (Mitragyna speciosa): A Systematic Review. Journal of Addiction Medicine. 2026;20(6):e230-e238. doi:10.1097/adm.0000000000001663

BibTeX
@article{Calicdan2026,
  author = {Calicdan, Xavier Alexander and Kopczynski, Anika and Medina, Edwin and Singh, Samantha and Sotelo, Diana and Wu, Alexander Chen and Suzuki, Joji},
  title = {Liver Injury Associated With Kratom (Mitragyna speciosa): A Systematic Review},
  journal = {Journal of Addiction Medicine},
  year = {2026},
  volume = {20},
  number = {6},
  pages = {e230--e238},
  doi = {10.1097/adm.0000000000001663}
}
Kostenlos starten →